Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice

Neuropharmacology. 2010 Jul-Aug;59(1-2):20-30. doi: 10.1016/j.neuropharm.2010.03.012. Epub 2010 Apr 2.

Abstract

Excitotoxin induces neurodegeneration via glutamatergic activation or oxidative stress, which means that the blockade of glutamate receptors and the scavenging of free radicals are potential therapeutic targets in neurodegenerative diseases. Sinapic acid (SA) has a GABA(A) receptor agonistic property and free radical scavenging activity. We investigated the neuroprotective effects of SA on kainic acid (KA)-induced hippocampal brain damage in mice. SA (10 mg/kg) by oral administration has an anticonvulsant effect on KA-induced seizure-like behavior. Moreover, SA (10 mg/kg) significantly attenuated KA-induced neuronal cell death in the CA1 and CA3 hippocampal regions when administered as late as 6 h after KA. In addition, flumazenil, a GABA(A) antagonist, blocked the effect of SA administered immediately after KA but not the effect of SA administered 6 h after KA. This late protective effect of SA was accompanied by reduced levels of reactive gliosis, inducible nitric oxide synthase expression, and nitrotyrosine formation in the hippocampus. In the passive avoidance task, KA-induced memory impairments were ameliorated by SA. These results suggest that the potential therapeutic effect of SA is due to its attenuation of KA-induced neuronal damage in the brain via its anti-convulsive activity through GABA(A) receptor activation and radical scavenging activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants / chemistry
  • Anticonvulsants / therapeutic use
  • Avoidance Learning / drug effects
  • Cell Death / drug effects
  • Coumaric Acids / chemistry
  • Coumaric Acids / therapeutic use*
  • Disease Models, Animal
  • Flumazenil / pharmacology
  • GABA Agonists / pharmacology
  • GABA Antagonists / pharmacology
  • GABA-A Receptor Agonists
  • GABA-A Receptor Antagonists
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Kainic Acid / toxicity*
  • Male
  • Memory Disorders / chemically induced
  • Memory Disorders / drug therapy
  • Mice
  • Mice, Inbred ICR
  • Neurodegenerative Diseases / chemically induced
  • Neurodegenerative Diseases / drug therapy*
  • Neurodegenerative Diseases / pathology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / therapeutic use*
  • Neurotoxins / toxicity*
  • Seizures / chemically induced
  • Seizures / drug therapy

Substances

  • Anticonvulsants
  • Coumaric Acids
  • GABA Agonists
  • GABA Antagonists
  • GABA-A Receptor Agonists
  • GABA-A Receptor Antagonists
  • Neuroprotective Agents
  • Neurotoxins
  • Flumazenil
  • sinapinic acid
  • Kainic Acid